JPY 1,766.00
+2.38%Sep 14, 2026, 09:38 UTC
Santen Pharmaceutical announced that China's drug regulator accepted its marketing approval application for the myopia-progression-suppressing eye drop Ryjusea.
Source:Aug 5, 2026, 09:00 UTC
Santen Pharmaceutical announced it will join the inaugural Global Summit for Eye Health as a High-Impact Partner, organized by IAPB in collaboration with WHO, to help shape the Global Eye Health Compact and unveil its global eye health commitment.